Cell and Gene Logistics

31. Evaluating And Qualifying Temperature Managed Shippers 3/31/2020

    The maintenance of cold chain product integrity across the entire supply chain demands rigorous processes and cold chain expertise of the highest caliber—from packaging, handling, storage & distribution of temperature sensitive Investigational Medicinal Products (IMP), all the way to the investigator site. This eBook provides insight into how we qualify shipping options with a case study example of a ‘return and reuse shipper pilot’ which delivered very positive results

32. Top Tips For Preventing Customs Chaos 2/4/2020

    See how selecting the right IOR, getting an early start, following the rules, perfecting the paperwork, and knowing the numbers can streamline your customs process.

33. Total Transportation Management 2/4/2020

    The transportation of life science shipments has become increasingly more complex over the years, with patient pools expanding, often to remote locations across the globe. In addition, the growth of biologics has added increased complexity to the supply chain due to cold chain handling, storage and distribution requirements across the supply chain.

34. The Challenge Of Keeping Cool 2/4/2020

    From manufacturing through delivery to the patient, pharmaceutical drugs must be maintained within strict temperature guidelines to protect the efficacy of the product. This level of protection is not exclusive to refrigerated and frozen product. Even ambient product (generally 15°C to 25°C) needs protection in climates where it can be at risk of becoming too warm or cold.

35. Securing Today’s Biomanufacturing Supply Chain Using Transformative Supply 1/10/2020

    Managing today’s supply chain complexity begins by transforming historically transactional relationships to those that drive suppliers to value-added status, working toward shared customer goals.

36. Safely Transporting Medicines To Patients 1/2/2020

    Do pharma companies underestimate supply chain challenges? Much can go wrong when sending a therapy from A to B, but the right collaborations can mitigate risk.

37. The Need For Digital Networks To Support Cell And Gene Therapies 12/30/2019

    Cell and gene therapies have a level of complexity from a supply chain perspective that needs new approaches, including a high level of information sharing and integration. This topic was covered from different perspectives at two recent conferences.

38. Digitization Of The Supply Chain: Challenges In Scaling Up Cell & Gene Therapy 10/9/2019

    This white paper discusses the unique biopharmaceutical supply chain challenges of Cell & Gene therapy logistics and recommends forward-thinking solutions to address them. Successfully overcoming these logistics challenges is essential in order to scale up C&G therapies to treat large numbers of patients worldwide.

39. Does Blockchain Make Sense For The Cell & Gene Therapy Supply Chain? 9/12/2019

    Understanding the impact and requirements for a clearly defined supply chain strategy and implementing this into the complex environment of cell and gene therapies is not a simple task. It requires dedication and participation from all the stakeholders across the development-to-delivery life cycle. All the details need to be defined, simulation models developed, and risk assessed — and remediation plans put in place. 

40. 10 Things You Should Know About Dry Shippers Before Shipping High Value Biologics 7/23/2019

    This infographic offers insight into the 10 most important things to consider when shipping high-value biologics in dry shippers. Download it learn more about data loggers, temperature holds, orientation, shipping racks, and much more.